This study investigates solid tumors with the p53 R175H mutation. It focuses on understanding how the investigational medication works in patients with this condition.
The study evaluates the safety, tolerability, and activity of the investigational medication. This study investigates how the body processes the medication and its effects.
- Who can participate: Adults aged 18 and older with advanced solid tumors that have a p53 R175H mutation can participate. Participants must be HLA-A*02:01 positive and have tumors that progressed after standard therapy.
- Study details: Participants will receive an investigational medication to study its effects. The study will explore safety and how the body responds to the medication.
How understandable was the trial content above?
Hard to understand
Easy to understand